Zobrazeno 1 - 10
of 19
pro vyhledávání: '"O. N. Boldyreva"'
Autor:
O V Knyazev, A V Kagramanova, N A Fadeeva, A A Lishchinskaya, O N Boldyreva, K K Noskova, R B Gudkova, A G Konoplyannikov, A I Parfenov
Publikováno v:
Терапевтический архив, Vol 90, Iss 2, Pp 47-52 (2018)
Crohn's disease (CD) is a chronic, recurring disease of the gastrointestinal tract of unclear etiology. One of the new approaches to CD therapy is the use of the possibilities of stem cells, in particular, mesenchymal stromal cells (MSCs). Currently,
Externí odkaz:
https://doaj.org/article/45c7f64efdc442a6b617dbc12f9af695
Autor:
O V Knyazev, A V Kagramanova, I N Ruchkina, N A Fadeeva, A A Lishchinskaya, O N Boldyreva, E Yu Zhulina, P L Shcherbakov, N V Orlova, M V Kirova, A I Parfenov
Publikováno v:
Терапевтический архив, Vol 89, Iss 2, Pp 20-27 (2017)
Aim. To evaluate the efficacy and safety of adalimumab (ADA) in patients with Crohn’s disease (CD) treated at the Department of Inflammatory Bowel Diseases, Moscow Clinical Research and Practical Center, and to determine the predictors of a therapy
Externí odkaz:
https://doaj.org/article/0b5d77866b324af1bbbd51c41b9389ca
Publikováno v:
Терапевтический архив, Vol 88, Iss 2, Pp 44-48 (2016)
Conclusion. MSC application increases efficacy of anti-inflammatory treatment in patients with acute exacerbation of UC.
Externí odkaz:
https://doaj.org/article/2c8237d847664832b4984d65f5c8d46f
Autor:
O V Kniazev, A I Parfenov, A G Konopliannikov, I N Ruchkina, A A Churikova, S V Bykova, E A Albulova, O N Boldyreva, N A Fadeeva, A A Lishchinskaia
Publikováno v:
Терапевтический архив, Vol 87, Iss 2, Pp 39-44 (2015)
Aim. To compare the safety of therapy in patients with ulcerative colitis (UC) and Crohn's disease (CD) who have received combination anti-inflammatory therapy using bone marrow mesenchymal stromal cells (MSC) and standard therapy with 5-aminosalicyl
Externí odkaz:
https://doaj.org/article/f079545ef0244687b7988f936e1aca3b
Autor:
A I Parfenov, O N Boldyreva, I N Ruchkina, O V Kniazev, V É Sagynbaeva, P L Shcherbakov, S G Khomeriki, L B Lazebnik, A G Konopliannikov
Publikováno v:
Терапевтический архив, Vol 86, Iss 2, Pp 32-38 (2014)
AIM: To define the value of adhesion molecules (sVCAM-1 integrin, P-selectin, E-selectin, and L-selectin) for the prediction and evaluation of the efficiency of treatment in patients with ulcerative colitis (UC) and Crohn's disease/MATERIAL AND METHO
Externí odkaz:
https://doaj.org/article/4750231d7d85479dae179af19c34ea82
Autor:
Bonan Li, O. N. Boldyreva
Publikováno v:
Culture Space of Russian World. 5:36-41
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb8bafa5f0af6d5488f748e315b86c27
https://doi.org/10.24147/2782-2532.2021.5(1).36-41
https://doi.org/10.24147/2782-2532.2021.5(1).36-41
Publikováno v:
Glavnyj mekhanik (Chief Mechanic). :32-42
The studies of the dependence of acoustic characteristics on the microstructure of chromium-molybdenum-vanadium steels in various structural states after long term operation are presented. The meaning of the acoustic limit state criterion, which repr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c5d0f36c7891b54e6e414c78ff40e87
https://doi.org/10.33920/pro-2-2010-03
https://doi.org/10.33920/pro-2-2010-03
Autor:
Oleg Knyazev, A I Parfenov, A A Lishchinskaya, R.B. Gudkova, O N Boldyreva, N A Fadeeva, A G Konoplyannikov, A V Kagramanova, K K Noskova
Publikováno v:
Терапевтический архив, Vol 90, Iss 2, Pp 47-52 (2018)
Crohn's disease (CD) is a chronic, recurring disease of the gastrointestinal tract of unclear etiology. One of the new approaches to CD therapy is the use of the possibilities of stem cells, in particular, mesenchymal stromal cells (MSCs). Currently,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fb02c6242d449f5032d98b5a9536e13
https://ter-arkhiv.ru/0040-3660/article/viewFile/32819/pdf
https://ter-arkhiv.ru/0040-3660/article/viewFile/32819/pdf
Publikováno v:
Chemical and Petroleum Engineering. 53:610-613
Methods for the organization of safe manufacturing processes and for the control of technological risk in Russia and abroad are considered. The structure, problems, and types of estimation (levels) of risk and the advantages of the method of Risk Bas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a84880ba711c4f74c78cf224e8e54259
https://doi.org/10.1007/s10556-018-0389-z
https://doi.org/10.1007/s10556-018-0389-z
Autor:
E.Yu. Zhulina Zhulina, P L Shcherbakov, Oleg Knyazev, O N Boldyreva, N A Fadeeva, M V Kirova, A I Parfenov, A V Kagramanova, I N Ruchkina, N V Orlova, A A Lishchinskaya
Publikováno v:
Терапевтический архив, Vol 89, Iss 2, Pp 20-27 (2017)
To evaluate the efficacy and safety of adalimumab (ADA) in patients with Crohn's disease (CD) treated at the Department of Inflammatory Bowel Diseases, Moscow Clinical Research and Practical Center, and to determine the predictors of a therapy respon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31e535de6842239a4ac7435d56b20293
https://ter-arkhiv.ru/0040-3660/article/viewFile/32155/pdf
https://ter-arkhiv.ru/0040-3660/article/viewFile/32155/pdf